Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4594423

TP-1287
Phase I
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Phase I
CN1CC[C@H](c2c(OP(=O)(O)O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1

Basic Information

ChEMBL ID CHEMBL4594423
Name TP-1287
Phase Phase I
Structure Type MOL
InChI Key YRNFLVUMZIRYKY-BLLLJJGKSA-N
Active Moiety CHEMBL428690

Known Names

Alvocidib phosphate Alvocidib prodrug tp-1287 Tp 1287 Tp-1287 TP1287
2
Targets
4
Activities
1
Assay Types
1
PK Parameters
8
Publications
5
Known Names
3
Indications

Molecular Properties

481.8
MW (Da)
3.07
ALogP
7
HBA
4
HBD
140.7
PSA (Ų)
0.41
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Single Enantiomer

Flags

Prodrug

Extended Properties

Molecular Formula C21H21ClNO8P
MW 481.83
Aromatic Rings 3
Heavy Atoms 32
NP-Likeness 0.92

Indications

Liposarcoma Sarcoma, Ewing Sarcoma, Synovial

Activity Summary

IC50 4 meas. best 8.0

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Cyclin-dependent kinase 9
CHEMBL3116
IC50 8.0 7.3867 10.0 3
Cyclin-dependent kinase 12
CHEMBL3559692
IC50 8.0 8.0 10.0 1

Pharmacokinetic Data

Parameter Value Units Species
F 182.3 % Mus musculus

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
32866383 10.1021/acs.jmedchem.0c00744 No relevant target 2
32866383 10.1021/acs.jmedchem.0c00744 Cyclin-dependent kinase 9 1
32866383 10.1021/acs.jmedchem.0c00744 ADMET 1
32866383 10.1021/acs.jmedchem.0c00744 MV4-11 1
35814933 10.1039/d2md00040g Cyclin-dependent kinase 9 1
35814933 10.1039/d2md00040g MV4-11 1
38569434 10.1016/j.ejmech.2024.116333 Cyclin-dependent kinase 9 1
38569434 10.1016/j.ejmech.2024.116333 Cyclin-dependent kinase 12 1

Data from ChEMBL 36 via Core Engine